Vin Colicchio has over 35 years in the pharmaceutical industry leading manufacturing and supply chain operations. He has extensive knowledge and experience leading end-to-end production and supply operations for oral solid dosage, semi-solids, liquids and transdermals in both the brand and generics categories. Vin’s background includes leadership over several U.S. and international manufacturing sites, integration of acquisitions and execution of new product launches.
Vin’s previous role was at Dr. Reddy’s Laboratories, where he served as Vice President of Supply Chain and External Manufacturing for North America, leading product supply for the Rx, SRx and OTC businesses. He had responsibility for supply operations of generics products manufactured by the Dr. Reddy’s manufacturing network based in India and the U.S. In addition, he oversaw the external manufacturing network of over 45 CMO’s and CPO’s based in the US, Canada and Europe. He managed supply and demand planning, procurement, inbound logistics, and supported new product launches. One key achievement was the acquisition and integration of the Mayne Pharma generic product portfolio and supply chain, including 16 CMO’s and CPO’s, to drive growth for North America.
Prior that, Vin was the Vice President of Operations at Amneal Pharmaceuticals overseeing manufacturing operations based in New Jersey. Vin also served as the Senior Vice President of Operations for G&W Laboratories based in South Plainfield, New Jersey.
Previously, Vin held positions of increasing responsibility at GlaxoSmithKline, Stiefel Laboratories, UCB Pharma, Elan and Wyeth.
Vin has a B.S. in Biochemical Engineering from Rutgers University and earned his MBA in Management from the Keller Graduate School of Management of DeVry University.
Operations goal is to ensure that Cosette manufactures and supplies our high quality products to our customers and patients 100% on time and in full. Improving our supply chain capabilities, while integrating new products and suppliers into our manufacturing network is a competitive advantage that will differentiate Cosette from the competition. By building a scalable, resilient supply infrastructure and fostering a culture of operational excellence, Cosette can reliably deliver our products while preparing for the opportunities of tomorrow. My focus is on creating the capabilities that will enable Cosette to expand access, accelerate growth and improve the lives of the patients it serves.
